News
13h
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...
If I am unable to access a vaccine in the future and get a nasty case of COVID, I'll know where to point the finger and so will millions of others.
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
Private equity ownership of psychiatric hospitals grew rapidly from 2013 to 2021, but the quality of care did not diminish ...
Top U.S. vaccine regulator Vinay Prasad and FDA Commissioner Marty Makary, both of whom have been critical of U.S. COVID ...
FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...
1h
KFF Health News on MSNTrump’s Team Cited Safety in Limiting Covid Shots. Patients, Health Advocates See More Risk.Vaccine opponents and skeptics in charge of federal health agencies — starting at the top with Health and Human Services ...
11h
India Today on MSNCovid-19 vaccine rules may change from 2025: What you should knowThe FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results